SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

Guggenheim Securities Downgrades Seattle Genetics to Neutral

Guggenheim Securities analyst Michael Schmidt downgrades Seattle Genetics (NASDAQ:SGEN) from Buy to Neutral.

Benzinga · 01/02/2020 13:02

Guggenheim Securities analyst Michael Schmidt downgrades Seattle Genetics (NASDAQ:SGEN) from Buy to Neutral.